First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade
Clinical trial NCT01215344 · COMPLETED
Trial details
- NCT number
- NCT01215344
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2015-11-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.